Thomas M Shinnick

Title: The Innovations of Thomas M. Shinnick

Introduction

Thomas M. Shinnick is a notable inventor based in Del Mar, California. He has made significant contributions to the field of biotechnology, particularly in the study of Mycobacterium tuberculosis. With a total of six patents to his name, Shinnick's work has advanced our understanding of infectious diseases and potential treatments.

Latest Patents

Shinnick's latest patents focus on mycobacterial recombinants and peptides. He has disclosed recombinant proteins consisting of 540 and 517 amino acid residues encoded by the genome of Mycobacterium tuberculosis. These patents include vectors for propagating their DNA sequences and methods for expressing the proteins. Additionally, he has described peptides that correspond substantially to the sequences of these proteins, along with methods for their use. His work also encompasses polymers containing peptide repeating units corresponding to the 540 residue protein and polymers containing 517 protein pentapeptides as repeating units.

Career Highlights

Throughout his career, Shinnick has worked with esteemed organizations such as the Scripps Clinic and Research Foundation and The Scripps Research Institute. His research has played a crucial role in the development of innovative solutions for combating tuberculosis and other mycobacterial infections.

Collaborations

Shinnick has collaborated with notable individuals in the field, including Richard Allen Houghten and Percy Minden. These partnerships have further enriched his research and contributed to the advancement of biotechnology.

Conclusion

Thomas M. Shinnick's contributions to the field of biotechnology, particularly in relation to Mycobacterium tuberculosis, highlight his innovative spirit and dedication to scientific advancement. His patents and collaborations reflect a commitment to improving health outcomes through research and innovation.